Evidence map›Paper›PMID 16720310›Full record

ReviewFrontiers in bioscience : a journal and virtual library2006

Corticotropin releasing hormone and the skin.

Andrzej Slominski, Blazej Zbytek, Michal Zmijewski, Radomir M Slominski, Sobia Kauser, Jacobo Wortsman, Desmond J Tobin

Open access · bronzeAbstract readReview
In one paragraph

Review in Frontiers in bioscience : a journal and virtual library, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 149 citations in OpenAlex.

  1. Review
  2. Molecular Targets in Modern Cosmetic Science.Molecules (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. The Role of Selected Proteins in the Pathogenesis of Psoriasis.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Cutaneous innervation in impaired diabetic wound healing.Translational research : the journal of laboratory and clinical medicine · 2021
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Andrzej SlominskiDepartment of Pathology, University of Tennessee Health Science Center, Memphis, TN 38163, USA. aslominski@utmem.edu
Blazej Zbytek
Michal Zmijewski
Radomir M Slominski
Sobia Kauser
Jacobo Wortsman
Desmond J Tobin
University of Tennessee Health Science Center · US

Funding

Role of CRH in skin physiology and pathologyR01AR047079 · NIAMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SLOMINSKI, ANDRZEJ T · 2002 to 2004
$708k
NIAMS NIH HHS 1R01-AR047079NIAMS NIH HHS R01 AR047079
6 · The paper itself

Abstract

Cotricotropin-releasing hormone (CRH) and related peptides are produced in skin that is dependent on species and anatomical location. Local peptide production is regulated by ultraviolet radiation (UVR), glucocorticoids and phase of the hair cycle. The skin also expresses the corresponding receptors (CRH-R1 and CRH-R2), with CRH-R1 being the major receptor in humans. CRH-R1 is expressed in epidermal and dermal compartments, and CRH-R2 predominantly in dermal structures. The gene coding for CRH-R1 generates multiple isoforms through a process modulated by UVR, cyclic adenosine monophosphate (cAMP) and phorbol 12-myristate 13-acetate. The phenotypic effects of CRH in human skin cells are largely mediated by CRH-R1alpha through increases in concentrations of cAMP, inositol triphosphate (IP3), or Ca2+ with subsequent activation of protein kinases A (PKA) and C (PKC) dependent pathways. CRH also modulates the activity of nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-kappaB), activator protein 1 (AP-1) and cAMP responsive element binding protein (CREB). The cellular functions affected by CRH depend on cell type and nutritional status and include modulation of differentiation program(s), proliferation, viability and immune activity. The accumulated evidence indicates that cutaneous CRH is also a component of a local structure organized similarly to the hypothalamo-pituitary-adrenal axis.

Indexed as

Skin Physiological PhenomenaAlternative SplicingCell Culture TechniquesCorticotropin-Releasing HormoneCRF Receptor, Type 1Hair FollicleHumansHypothalamo-Hypophyseal SystemPeptidesPhenotypePituitary-Adrenal SystemProtein IsoformsReceptors, Corticotropin-Releasing HormoneSecond Messenger SystemsSignal TransductionSkinCorticotropin-Releasing HormoneCRF Receptor, Type 1PeptidesProtein IsoformsReceptors, Corticotropin-Releasing HormoneUrocortins

Identifiers

PMID16720310
PMCPMC1847336
OpenAlexW2002289379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.